SCHEMBL5611

SCHEMBL5611

COC[C@]1(O)CC[C@]2(CCN(c3ccc(C(C)C)cc3)C2)CC1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 16/20 0.40
CYP2C19 P33261 7/20 0.40
TSHR P16473 3/20 0.40
ALDH1A1 P00352 7/20 0.39
USP2 O75604 6/20 0.39
HSD17B10 Q99714 5/20 0.39
CYP1A2 P05177 5/20 0.39
CYP2C9 P11712 5/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPK1 P28482 4/20 0.39
HIF1A Q16665 4/20 0.39
ALOX15 P16050 1/20 0.39
CYP2D6 P10635 4/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5546 0.85 LIPE (0.44) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5655 0.84 CYP3A4 (0.40) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5989 0.82 CYP3A4 (0.40) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5381 0.81 CYP3A4 (0.39) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5391 0.75 CYP3A4 (0.35) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5166 0.74 CYP3A4 (0.37) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5165 0.74 CYP3A4 (0.37) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL24352428 0.74 CCR6 (0.41) CYP3A4CYP2C19ALDH1A1USP2HSD17B10
SCHEMBL1589766 0.73 LIPE (0.57)
SCHEMBL1589769 0.73 LIPE (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed